• SENSEX 72,529.07
    -242.65 (--0.33%)
  • BANKNIFTY 54,259.95
    -211.70 (--0.39%)
  • Cube Highways
    156.41 162.00(%)
  • NSE
    1,793.70 1,878.00(%)
  • 360 ONE
    1,019.75 906.20(%)
  • SS Retail
    775.00 888.00(%)
  • Cupid
    292.35 298.95(%)
  • R Systems Intl.
    305.25 446.55(%)
  • GE Vernova T&D
    4,225.00 5,650.00(%)
  • Lords Mark Industries
    84.89 60.00(%)
  • PB Fintech.
    1,076.35 1,076.35(%)
  • Azad Engineering
    2,997.65 2,997.65(%)
  • Hero Motors
    140.75 156.03(%)
  • HDFC Bank
    720.00 1,020.35(%)
  • Reliance Industries
    1,182.05 1,182.05(%)
  • Delhivery
    418.15 524.25(%)
  • Ather Energy
    1,404.00 542.20(%)
  • Varmora Granito
    163.45 163.45(%)
  • Bharti Airtel
    1,788.00 2,174.70(%)
  • Indian Hotels Co
    725.50 757.10(%)
  • ICICI Lombard
    1,498.00 1,423.95(%)
  • Bajaj Finance
    961.65 788.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Speciality Medicines Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 93628.0
  • ISIN : INE0R0M01014
158.00 -7 (-4.18%)
  • As on 29 Sep 2026 (EOD)

  • Today’s Low

    155.50

  • Today’s High

    160.00

  • Open

    155.50

  • Perv Close

    164.90

  • 52W Low

    121.10

  • 52W High

    381.20

Key Indicators

  • P/E(TTM)

    10.65

  • Mar.Cap (₹Cr.)

    138.82

  • Div & Yield %

    0.00

  • Book Value(₹)

    81.03

  • Debt-Equity Ratio

    -4.18

  • AGM Date

    29-Sep-2026

  • EPS

    14.83

  • P/E Ratio

    10.65

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    138.82

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    8.79

  • BV (₹)

    81.00

  • Sales( ₹ in Cr.)

    75.29

  • NP (in Cr.)

    13.03

  • NP Var(%)

    81.0

  • Div%

    0.0

  • CPS (₹)

    15.00

  • EPS (₹)

    14.80

  • Traded Value (₹ in Lakhs)

    138.82

  • 52 Week High

    381.20

  • 52 Week Low

    121.10

  • Price BSE

    158.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    138.82

  • P/C Ratio

    10.50

  • P/E Ratio

    10.70

  • Price Vs.BV

    14.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar
INCOME :            
Sales Turnover 75.29 58.27 27.52 23.24 40.44 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 75.29 58.27 27.52 23.24 40.44 -
Other Income 0.83 0.27 0.13 0.02 0.00 -
Stock Adjustments 10.94 9.34 3.44 4.11 0.48 -
Total Income 87.06 67.88 31.09 27.37 40.92 -
EXPENDITURE :            
Raw Materials 65.07 51.52 21.64 20.39 35.52 -
Power and Fuel Cost 0.02 0.03 0.02 0.02 0.01 -
Employee Cost 1.73 2.08 0.88 0.75 0.82 -
Other Manufacturing Expenses 0.08 0.13 0.08 0.16 0.16 -
Selling and Administration Expenses 4.36 4.36 3.06 1.96 1.97 -
Miscellaneous Expenses 1.29 0.36 0.01 0.50 0.17 -
Employee Benefit Expenses 1.73 2.08 0.88 0.75 0.82 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 72.54 58.49 25.69 23.77 38.65 -
Operating Profit 14.51 9.40 5.41 3.60 2.28 -
Interest 1.32 0.51 0.62 0.35 0.03 -
Gross Profit 13.19 8.89 4.79 3.25 2.25 -
Depreciation 0.17 0.20 0.23 0.30 0.11 -
Profit Before Tax 13.02 8.69 4.56 2.95 2.14 -
Current Tax 0.00 0.00 1.64 1.29 0.66 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax -0.01 1.49 -0.02 -0.02 0.00 -
Reported Net Profit 13.03 7.20 2.93 1.69 1.48 -
Extraordinary Items 0.01 0.00 0.00 0.00 0.00 -
Adjusted Net Profit 13.02 7.20 2.93 1.69 1.48 -
Adjustment below Net Profit -1.60 0.00 0.00 -1.12 0.00 -
P & L Balance brought forward 13.86 6.66 2.11 1.48 0.00 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down 25.29 13.86 5.04 2.05 1.48 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 14.83 11.18 5.73 4.42 70.45 -
Earnings Per Share(Adj)-Unit Curr 14.83 - - - - -
Book Value 81.03 47.58 29.44 15.36 92.02 -
Book Value(Adj)-Unit Curr 81.03 - - - - -

Shareholding Pattern

  • Promoter Group

    43.43%

  • Public Share Holding

    56.57%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,815,500 43.43 3,815,500 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,815,500 43.43 3,815,500 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 21,000 0.24 21,000 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 21,000 0.24 21,000 2
2] Non Institution
Bodies Corporate 93,146 1.06 93,146 8
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 29,000 0.33 29,000 7
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 360,219 4.10 360,219 69
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,144,480 24.41 2,144,480 21
Individuals holding nominal share capital up to Rs. 1 lakh 2,122,451 24.16 2,122,451 639
Market Maker 150,000 1.71 150,000 1
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,949,296 56.33 4,949,296 749
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,785,796 100.00 8,785,796 757

Company Background

Speciality Medicines LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Speciality Medicines Ltd
  • BSE Code : 93628.0
  • ISIN : INE0R0M01014

  • Incorporation Year

    2021

  • Registered Office

    913 One World West S.No.396 FP
    Village-Vejalpur, Ahmedabad,
    Gujarat-380051

  • Telephone

    +91 22 4604 5344

  • FAX

  • Chairman

    Parth B Goyani

  • Managing Director

    Parth B Goyani

  • Company Secretary

    Rashi Kaur Gurcharansingh Daang

  • Auditor

    A K Ostwal & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Skyline Financial Services Pvt
    D-153/A 1st Flr,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Speciality Medicines Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 27,266.65 7,217.19 6,929.05 35.88 43.78
Astrazeneca Phar 6,254.35 2,304.07 2,275.58 92.18 27.86
Glaxosmi. Pharma 2,787.25 3,932.76 3,790.20 44.52 58.17
Novartis India 1,933.35 393.10 354.33 48.82 15.94
Cipla 1,383.00 20,102.60 18,979.95 36.35 13.88
Bliss GVS Pharma 710.05 773.53 729.81 65.99 12.51
Fermenta Biotec. 549.30 474.15 450.25 25.64 18.77
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Guj. Themis Bio. 404.40 168.25 165.82 108.13 18.05
Ambalal Sarabhai 39.24 19.52 3.94 72.67 6.77